1. Scrip
  2. >>Archive

Sun finally gains control of Taro as takeover saga draws to a close

 
• By Anju Ghangurde

Sun Pharmaceutical Industries of India has completed the buyout of a controlling interest in Taro Pharmaceutical Industries, bringing to an end an acrimonious takeover battle spanning more than three years.

Sun Pharmaceutical Industries of India has completed the buyout of a controlling interest in Taro Pharmaceutical Industries, bringing to an end an acrimonious takeover battle spanning more than three years.

Sun said that its subsidiaries had raised their holding in Taro to 48.7% (from about 36%) and voting rights to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Scrip

What Incyte Investors Expect From New CEO Bill Meury

 
• By Andrew McConaghie

Fresh from having sold Anthos to Novartis, the new CEO is expected to update the oncology and dermatology-focused firm's strategy.

Bayer Buoyant After EU Nod For Twice-Yearly Eylea

 
• By Kevin Grogan

Green light follows a recent rejection by the US FDA to partner Regeneron's request for an extension to the dosing interval.

Executives On The Move: New CEO At Atalanta Therapeutics

Recent moves in the industry include C-suite changes at Atalanta Therapeutics and Climb Bio, plus seven companies get new CMOs.